When Should Clinicians Act on Non-Statistically Significant Results From Clinical Trials?

JAMA. 2020 Jun 9;323(22):2256-2257. doi: 10.1001/jama.2020.3508.
No abstract available

MeSH terms

  • Acute Kidney Injury / epidemiology
  • Acute Kidney Injury / etiology
  • Coronary Angiography / mortality
  • Coronary Angiography / statistics & numerical data
  • Evidence-Based Practice* / economics
  • Fluid Therapy / methods
  • Humans
  • Hydroxyethyl Starch Derivatives / adverse effects
  • Lactic Acid / blood
  • Out-of-Hospital Cardiac Arrest / diagnostic imaging
  • Out-of-Hospital Cardiac Arrest / mortality
  • Perfusion / methods
  • Plasma Substitutes / adverse effects
  • Postoperative Complications / etiology
  • Postoperative Complications / mortality
  • Randomized Controlled Trials as Topic / economics
  • Randomized Controlled Trials as Topic / methods
  • Randomized Controlled Trials as Topic / standards
  • Randomized Controlled Trials as Topic / statistics & numerical data*
  • Research Report / standards*
  • Resuscitation / methods
  • Saline Solution / administration & dosage
  • Shock, Septic / blood
  • Shock, Septic / mortality

Substances

  • Hydroxyethyl Starch Derivatives
  • Plasma Substitutes
  • Saline Solution
  • Lactic Acid